Literature DB >> 15608535

The incidence of herpes zoster is less likely than other opportunistic infections to be reduced by highly active antiretroviral therapy.

Philippe Vanhems, Laurent Voisin, Angèle Gayet-Ageron, Christian Trepo, Laurent Cotte, Dominique Peyramond, Christian Chidiac, Jean-Louis Touraine, Jean-Michel Livrozet, Jacques Fabry, Nicolas Voirin.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15608535     DOI: 10.1097/00126334-200501010-00020

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  8 in total

Review 1.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

2.  Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Authors:  Adriana Weinberg; Ann A Lazar; Gary O Zerbe; Anthony R Hayward; Ivan S F Chan; Rupert Vessey; Jeffrey L Silber; Rob R MacGregor; Kenny Chan; Anne A Gershon; Myron J Levin
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

3.  Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.

Authors:  Adriana Tovar Salazar; Ashley McKhann; Huichao Chen; Ronald J Bosch; Adriana Weinberg
Journal:  AIDS Res Hum Retroviruses       Date:  2019-07-16       Impact factor: 2.205

4.  Immune correlates of herpes zoster in HIV-infected children and youth.

Authors:  Adriana Weinberg; Sharon Huang; Lin-Ye Song; Terry Fenton; Paige Williams; Julie Patterson; Adriana Tovar-Salazar; Myron J Levin
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Trends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda.

Authors:  John Rubaihayo; Nazarius M Tumwesigye; Joseph Konde-Lule
Journal:  BMC Infect Dis       Date:  2015-04-17       Impact factor: 3.090

Review 6.  Incidence of Herpes Zoster in HIV-Infected Patients Undergoing Antiretroviral Therapy: A Systematic Review and Meta-analysis.

Authors:  Han-Chang Ku; Yi-Tseng Tsai; Sriyani-Padmalatha Konara-Mudiyanselage; Yi-Lin Wu; Tsung Yu; Nai-Ying Ko
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

7.  Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.

Authors:  Klaus Jansen; Burkhard Haastert; Claudia Michalik; Adrienne Guignard; Stefan Esser; Stephan Dupke; Andreas Plettenberg; Adriane Skaletz-Rorowski; Norbert H Brockmeyer
Journal:  BMC Infect Dis       Date:  2013-08-10       Impact factor: 3.090

8.  Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study.

Authors:  Chenglong Liu; Cuiwei Wang; Marshall J Glesby; Gypsyamber D'souza; Audrey French; Howard Minkoff; Toby Maurer; Roksana Karim; Mary Young
Journal:  AIDS Res Ther       Date:  2013-12-27       Impact factor: 2.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.